2020-07-03 15:17
MarktanalyseRupee jumps 44 paise to 74.60
Ähnliches Produkt：
Andere,Andere,Andere,Aktien,Andere,Andere
Marktanalyse：
The rupee appreciated 44 paise to 74.60 against the US dollar in early trade on Friday tracking weakness in the greenback and gains in the domestic equity market amid optimism over potential Covid-19 vaccine.
Forex traders said investors were bullish on emerging market assets following encouraging vaccine test results. Moreover, positive domestic equities, steady crude oil prices and weak US currency supported the local unit.
The rupee opened at 74.60 against the US dollar, registering a jump of 44 paise over its previous close.
It had settled at 75.04 against the greenback on Thursday.
Gefällt 0
FX3886574399
Trader
Aktueller Inhalt
In der Industrie
Event-A comment a day,Keep rewards worthy up to$27
In der Industrie
Nigeria Event Giveaway-Win₦5000 Mobilephone Credit
In der Industrie
Nigeria Event Giveaway-Win ₦2500 MobilePhoneCredit
In der Industrie
South Africa Event-Come&Win 240ZAR Phone Credit
In der Industrie
Nigeria Event-Discuss Forex&Win2500NGN PhoneCredit
In der Industrie
[Nigeria Event]Discuss&win 2500 Naira Phone Credit
Kategorie
Plattform
Ausstellung
IB
Rekrutierung
EA
In der Industrie
Markt
Index
Rupee jumps 44 paise to 74.60
Indien | 2020-07-03 15:17The rupee appreciated 44 paise to 74.60 against the US dollar in early trade on Friday tracking weakness in the greenback and gains in the domestic equity market amid optimism over potential Covid-19 vaccine.
Forex traders said investors were bullish on emerging market assets following encouraging vaccine test results. Moreover, positive domestic equities, steady crude oil prices and weak US currency supported the local unit.
The rupee opened at 74.60 against the US dollar, registering a jump of 44 paise over its previous close.
It had settled at 75.04 against the greenback on Thursday.
Andere
Andere
Andere
Aktien
Andere
Andere
Gefällt 0
Ich möchte auch kommentieren
Einreichen
0Kommentare
Es gibt noch keinen Kommentar. Mach den ersten
Einreichen
Es gibt noch keinen Kommentar. Mach den ersten